An interventional study of continuous peripheral nerve block in Knee Arthropathy, sponsored by Policlinico di Monza SpA. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-09-21.
Sponsored by Policlinico di Monza SpA · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 115 studies in Pain, Postoperative with a site in Italy — 17 open to participants now, 20 under way, none of them phase 3. Pain, Postoperative · Italy.
Among the 115 studies in Pain, Postoperative with a site in Italy, this one is the 4th largest by planned enrollment of the 86 interventional ones that give a count, is one of 5 that started in 2024, is one of 63 with no phase, reaches primary completion later than 13 of the 19 other live ones, and was the 94th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →17 of the 115 studies in Pain, Postoperative with a site in Italy are open now. Recruiting first, the newest first:
University of Rome Tor Vergata · Sites in Italy
Ages 18–75 · Women only
ASST Sette Laghi · Sites in Italy
Ages 18+
ASST Gaetano Pini-CTO · Sites in Italy
Ages 18+
AUSL Romagna Rimini · Sites in Italy
Ages 18–45 · Women only
Vittore Buzzi Children's Hospital · Sites in Italy
Ages 0–18
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
115 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 7 · Phase 4 11
First in 2006; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 436 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 79 across the 86 interventional studies, 120 across the 29 observational. Of the 72 that completed or were terminated, 6 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 115 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Policlinico di Monza SpA as lead sponsor.
Policlinico di Monza SpA has 1 study filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
6 of the studies in Pain, Postoperative with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06182059Policlinico di Monza SpAPersistent Post Surgical Pain After Total Knee Arthroplasty | 2027-01-31 |
| NCT07831096ASST Sette LaghiAnterior Suprascapular Versus Interscalene Block for Postoperative Analgesia After Arthroscopic Shoulder Surgery in the Outpatient Setting | 2027-02 |
| NCT06244732IRCCS Policlinico S. DonatoPain Control After Aortic EndoaneurYsmEctomy (POPEYE) | 2027-02 |
| NCT07239817ASST Gaetano Pini-CTOPENG Block + LIA For Endoprosthesis Surgery | 2027-02-28 |
| NCT07250373Fondazione Policlinico Universitario Agostino Gemelli IRCCSSerratus Posterior Superior Intercostal Plane (SPSIP) Block Versus Intercostal Nerve (ICN) Block in Patients Undergoing Uniportal-VATS. | 2027-04-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 115 studies in Pain, Postoperative with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patients undergone total knee replacement are randomized to receive a "fast track" regional anesthesia protocol or a "traditional" regional anesthesia continuous infusion by both a femoral and sciatic catheter to assess if this latter technique may reduce persistent postoperative pain six months after surgery
Patients undergone to primary total knee replacement with spinal anesthesia are randomized to receive a continuous adductor canal block infusion + an ipack block or a continuous femoral nerve block + a continuous sciatic nerve block just at the end of surgery. Both group will receive a multimodal analgesia with paracetamol, ketorolac, desametasone and morphine as a rescue.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
continuous adductor canal block and ipack block
Procedure: continuous peripheral nerve block
continuous femoral nerve block and continuous sciatic block
Procedure: continuous peripheral nerve block
continuous regional anesthesia in total knee replacement
Persistent post surgical pain
Numeric rating score (0-10) over 4 at the follow up 6-month after total knee replacement
Time frame: 0-6-month
acute postoperative pain
Numeric rating score (0-10) over 4 in POD0, POD1, POD2, POD3
Time frame: 0-72 hours
Morphine requirement
total morphine administration via PCA in POD0, POD1, POD2, POD3
Time frame: 0-72 hours
Started Jan 2024 (actual). Primary completion is estimated for Jan 2027, 36 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 36 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.